Varicose Ulcer
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
OrganogenesisApligraf
TheraclionECHOPULSE
SolventumProfore
Clinical Trials (3)
Total enrollment: 226 patients across 3 trials
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers
Start: Jul 2008Est. completion: Mar 20100
Phase 4Withdrawn
Treatment of Insufficient Superficial and Perforating Veins of the Lower Limb Using HIFU
Start: Aug 2017Est. completion: Aug 201850 patients
N/ACompleted
Cost Evaluation of Venous Leg Ulcers Management
Start: Dec 2015Est. completion: Jul 2018176 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.